Stay updated on Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the addition of new collaborators and a revision update, while key details about the study's methodology and inclusion/exclusion criteria have been removed.SummaryDifference25%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy for Body Dysmorphic Disorder Clinical Trial page.